Distinct Transcriptional Profile of PDZ Genes after Activation of Human Macrophages and Dendritic Cells.

PDZ antigen-presenting cells dendritic cells macrophages scaffold usage transcriptional signature

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
24 Jun 2022
Historique:
received: 19 05 2022
revised: 16 06 2022
accepted: 17 06 2022
entrez: 9 7 2022
pubmed: 10 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

The PDZ (PSD95, Dlg and ZO-1) genes encode proteins that primarily function as scaffolds of diverse signaling pathways. To date, 153 PDZ genes have been identified in the human genome, most of which have multiple protein isoforms widely studied in epithelial and neural cells. However, their expression and function in immune cells have been poorly studied. Herein, we aimed to assess the transcriptional profiles of 83 PDZ genes in human macrophages (Mɸ) and dendritic cells (DCs) and changes in their relative expression during cell PRR stimulation. Significantly distinct PDZ gene transcriptional profiles were identified under different stimulation conditions. Furthermore, a distinct PDZ gene transcriptional signature was found in Mɸ and DCs under the same phagocytic stimuli. Notably, more than 40 PDZ genes had significant changes in expression, with potentially relevant functions in antigen-presenting cells (APCs). Given that several PDZ proteins are targeted by viral products, our results support that many of these proteins might be viral targets in APCs as part of evasion mechanisms. Our results suggest a distinct requirement for PDZ scaffolds in Mɸ and DCs signaling pathways activation. More assessments on the functions of PDZ proteins in APCs and their role in immune evasion mechanisms are needed.

Identifiants

pubmed: 35806015
pii: ijms23137010
doi: 10.3390/ijms23137010
pmc: PMC9266728
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Consejo Nacional de Ciencia y Tecnología
ID : CB2015-250579
Organisme : Mexican Government
ID : Programa Presupuestal P016, Anexo 13 del Decreto del Presupuesto de Egresos de la Federación

Références

Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):103-116
pubmed: 29369778
J Immunol. 1996 Sep 1;157(5):1958-64
pubmed: 8757315
Traffic. 2017 Aug;18(8):491-504
pubmed: 28477369
Sci Rep. 2016 Jul 15;6:29783
pubmed: 27417573
Immunity. 2005 Jun;22(6):729-36
pubmed: 15963787
Nat Immunol. 2001 Apr;2(4):361-7
pubmed: 11276208
J Leukoc Biol. 2009 Mar;85(3):481-90
pubmed: 19052146
World J Gastroenterol. 2013 Jun 21;19(23):3583-95
pubmed: 23801859
Nat Immunol. 2007 Jun;8(6):584-91
pubmed: 17468759
J Virol. 2011 Nov;85(22):11544-56
pubmed: 21775458
Adv Ther (Weinh). 2019 Jul;2(7):1800143
pubmed: 32313833
J Immunol. 1996 Dec 15;157(12):5240-8
pubmed: 8955168
Nat Cell Biol. 2016 Nov;18(11):1244-1252
pubmed: 27694890
J Mol Med (Berl). 2021 Oct;99(10):1447-1458
pubmed: 34223928
Blood. 2003 Jul 15;102(2):672-81
pubmed: 12663451
Korean J Physiol Pharmacol. 2016 Mar;20(2):147-52
pubmed: 26937210
Int J Parasitol. 2003 Sep 30;33(11):1291-302
pubmed: 13678644
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
J Immunol. 2004 Feb 15;172(4):2307-15
pubmed: 14764699
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
J Mol Diagn. 2003 May;5(2):73-81
pubmed: 12707371
PLoS One. 2008 Jan 02;3(1):e1403
pubmed: 18167562
Science. 2003 Apr 18;300(5618):445-52
pubmed: 12702867
Immunol Rev. 2007 Oct;219:143-56
pubmed: 17850487
Genome Res. 2006 Aug;16(8):1056-72
pubmed: 16825666
Science. 2003 Feb 28;299(5611):1400-3
pubmed: 12610307
Nat Immunol. 2001 Apr;2(4):316-24
pubmed: 11276202
Sci Rep. 2020 Nov 12;10(1):19644
pubmed: 33184397
Curr Opin Immunol. 1997 Feb;9(1):4-9
pubmed: 9039775
J Biol Chem. 1998 Apr 17;273(16):9842-51
pubmed: 9545324
J Immunol. 2005 Mar 1;174(5):2738-45
pubmed: 15728482
J Biol Chem. 2002 Feb 8;277(6):4465-76
pubmed: 11694517
J Leukoc Biol. 2018 Apr;103(4):731-738
pubmed: 29345359
J Investig Allergol Clin Immunol. 2011;21(5):348-53
pubmed: 21905497
Front Immunol. 2018 Sep 11;9:2061
pubmed: 30254639
J Struct Biol X. 2020;4:100022
pubmed: 32289118
J Cell Sci. 2001 Sep;114(Pt 18):3219-31
pubmed: 11591811
J Immunol. 2019 Jun 1;202(11):3187-3197
pubmed: 31028120
J Immunol. 1996 Jan 1;156(1):310-5
pubmed: 8598478
Nat Rev Mol Cell Biol. 2015 Apr;16(4):232-44
pubmed: 25785716
J Leukoc Biol. 2020 Sep;108(3):883-893
pubmed: 32293058
Sci STKE. 2003 Apr 22;2003(179):RE7
pubmed: 12709532
J Biol Chem. 1990 Dec 5;265(34):21099-107
pubmed: 2147429
Annu Rev Neurosci. 2001;24:1-29
pubmed: 11283303
FASEB J. 2019 Oct;33(10):10607-10617
pubmed: 31336050
Proteomics. 2011 Mar;11(5):854-64
pubmed: 21280226
Nat Rev Immunol. 2009 Jan;9(1):47-56
pubmed: 19104498
Eur J Hum Genet. 2013 Mar;21(3):310-6
pubmed: 22892527
Cardiovasc Res. 2009 Jul 1;83(1):115-22
pubmed: 19380416

Auteurs

Jorge Rosas-García (J)

Laboratory of Transcriptomics and Molecular Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.
Department of Molecular Biomedicine, CINVESTAV, Mexico City 07360, Mexico.

Lucero A Ramón-Luing (LA)

Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.

Karen Bobadilla (K)

Laboratory of Transcriptomics and Molecular Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.

Marco Antonio Meraz-Ríos (MA)

Department of Molecular Biomedicine, CINVESTAV, Mexico City 07360, Mexico.

Edgar E Sevilla-Reyes (EE)

Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.

Teresa Santos-Mendoza (T)

Laboratory of Transcriptomics and Molecular Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH